TOTAL VOLUME:

$154.5b

24H VOL:

$271,200,656

24H TRANSACTIONS:

2,984,640,614

OPEN INTEREST:

$1,922,627,141

420,368

Markets across

40,352

events

MATCHED EVENTS:

4,484

PLATFORM COVERAGE:

5

Polymarket:

37%

VS.

Kalshi:

63%

BETA
Dashboards
Insights
Indices
API
Tour
All
Trending
Breaking
New
Ending Soon
Politics
Sports
Elections
Crypto
Companies
Financials
Economics
Other
Entertainment
Science and Technology
Vancouver vs Carolina: 3rd Period Spread
kalshi

Vancouver vs Carolina: 3rd Period Spread

Volume:
$784

Carolina wins by over 1.5 goals

 - Kalshi

Carolina wins by over 1.5 goals - Kalshi

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Oct 8, 2026

Closed: Oct 8, 9:40 PM EST

kalshi

Kalshi

View
Join Kalshi and score $25 for your first trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

Carolina wins by over 1.5 goals

View
0%
Yes 0¢No 100¢
—
N/A
$690
N/A
N/A
$667
Settled
No
kalshi

Vancouver wins by over 1.5 goals

View
0%
Yes 0¢No 100¢
—
N/A
$94
N/A
N/A
$79
Settled
No
kalshi

Carolina wins by over 2.5 goals

View
N/A
N/A
—
N/A
N/A
N/A
N/A
N/A
Settled
No
Total markets: 3

Description

This market focuses on determining which team secures a decisive lead in the final period of play during an NHL matchup. It evaluates whether the winning team achieves a margin of victory exceeding the specified threshold within that specific segment of the game.

Kalshi

The event determines whether either Vancouver or Carolina wins the third period of their NHL game scheduled for October 8, 2026, by more than 1.5 goals. The resolution hinges exclusively on the score differential within the third period, with overtime periods excluded from consideration. Should the game be postponed but commence within 48 hours of its original start time, the market remains active and resolves based on the official result. If the game is cancelled or fails to start within this 48-hour window, all markets resolve to a fair price, ensuring equitable treatment for all participants.